GlobeStar Therapeutics Corp — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/9587f3f9-7f92-4397-a789-b91c8568132c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $77 | 2019-10-01 – 2020-09-30 | evidence 0001161697-20-000517 |
| FY 2019 | $425 | 2018-10-01 – 2019-09-30 | evidence 0001185185-19-001771 |
| FY 2018 | $890 | 2017-10-01 – 2018-09-30 | evidence 0001185185-19-000011 |
| FY 2017 | $0 | 2016-10-01 – 2017-09-30 | evidence 0001185185-19-000011 |
| FY 2014 | $97.3k | 2013-10-01 – 2014-09-30 | evidence 0001161697-15-000043 |
| FY 2013 | $57.4k | 2012-10-01 – 2013-09-30 | evidence 0001161697-14-000042 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GlobeStar Therapeutics Corp — all facts · Net Income · Operating Income